View Author
patient disease survival protein creutzfeldt –jakob disease codon signi onset 14-3-3 mutation table prion neurol study level duration creutzfeldt group analysis prion protein gene –jakob codon 129 number gender month fi ndings 14-3-3 test creutzfeldt-jakob disease signi ficance signi ficantly fluence neurology value codon 129 genotype ficant prion diseases signi ficant 0.0 nding prpsc creutzfeldt-jakob tau levels effect department health result disease duration prpsc type pocchiari variable surveillance genotype brain-derived proteins gcjd patients gtse patients prnp gene spongiform ficantly reference codon 129 polymorphism e-mail polymorphism spongiform encephalopathies brain model ficance crude methionine iatrogenic cerebrospinal fl uid v 210i patients country wilcoxon test multivariate 10 years ladogana percentage stage analyses sensitivity
2 Most Recent Publications
|
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
(Article)
Ladogana, A. Sanchez-Juan, P. Gawinecka, J. Saiz, A. Calero, M. Duijn, C.M. van Pocchiari, M. Knight, R. Zerr, I. Mitrová, E. Green, A. Cuadrado-Corrales, N. Sánchez-Valle, R. Koscova, S. Aguzzi, A. Sklaviadis, T. Kulczycki, J. |
2009-10-01
|
|
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.
(Article)
Pocchiari, M. Puopolo, M. Brandel, J-P. Alperovitch, A. Zerr, I. Poser, S. Kretzschmar, H.A. Ladogana, A. Rietvald, I. Mitrová, E. Martinez-Martin, P. Pedro-Cuesta, J. de Croes, E.A. Glatzel, M. Cooper, S. Mackenzie, J. Duijn, C.M. van Will, R.G. Aguzzi, A. Budka, H. Gelpi, E. Collins, S.J. Lewis, V. Sutcliffe, T. Guilivi, A. Delasnerie-Laupretre, N. |
2004-10-01
|